(Q44676134)

5 December 2017

title

A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain (English)

1 reference

5 December 2017

0 references

0 references

Andreas Frei

1

1 reference

5 December 2017

Steen Andersen

series ordinal

2

1 reference

5 December 2017

Peter Hole

series ordinal

3

1 reference

5 December 2017

Niels-Henrik Jensen

series ordinal

4

1 reference

5 December 2017

publication date

1 January 2003

1 reference

Journal of Pain and Palliative Care Pharmacotherapy

5 December 2017

published in

1 reference

5 December 2017

volume

17

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

5-26

1 reference

Modelling in economic evaluation: an unavoidable fact of life

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Principles of economic evaluation for interventions of chronic musculoskeletal pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Pharmacoeconomics of chronic nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Management of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Long-term use of narcotic analgesics in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Chronic use of opioid analgesics in non-malignant pain: report of 38 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Long-term use of opioid analgesics for the treatment of chronic pain of nonmalignant origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Long-term opioid analgesic therapy for severe refractory lumbar spine pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl as treatment for chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl for chronic pain in AIDS: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

The costs of managing severe cancer pain and potential savings from transdermal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Treatment of cancer pain with transdermal fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Inhalation abuse of fentanyl patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl abuse and misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Markov models in medical decision making: a practical guide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

A model for analyzing the cost of the main clinical events after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

A critical review of the Delphi technique as a research methodology for nursing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

An introduction to Markov modelling for economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Long-term oral opioid therapy in patients with chronic nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Opioids in chronic non-malignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Adverse effects of systemic opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Opioid tolerance: the clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Transdermal drug delivery systems and skin sensitivity reactions. Incidence and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Durogesic) with controlled-release morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2FJ354V17N02_02

21 January 2018

Identifiers

DOI

10.1080/J354V17N02_02

1 reference

5 December 2017

1 reference